Balyasny Asset Management’s Heron Therapeutics HRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $25.3K | Buy |
|
|||||
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $94K | Buy |
|
|||||
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $735K | Buy |
|
|||||
|
2022
Q3 | $133K | Sell |
|
|||||
|
2022
Q2 | $1.41M | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $5.5M | Buy |
|
|||||
|
2021
Q3 | $5.14M | Buy |
|
|||||
|
2021
Q2 | $6.08M | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $4.68M | Buy |
|
|||||
|
2018
Q4 | $2.73M | Sell |
|
|||||
|
2018
Q3 | $9.98M | Buy |
|
|||||
|
2018
Q2 | – | Sell |
|
|||||
|
2018
Q1 | $45M | Buy |
|
|||||
|
2017
Q4 | $29.5M | Buy |
|
|||||
|
2017
Q3 | $18.4M | Sell |
|
|||||
|
2017
Q2 | $16.9M | Buy |
|
|||||
|
2017
Q1 | $18M | Buy |
|